Core Viewpoint - Corning Jereh Pharmaceutical-B (09966) announced a share buyback plan, indicating confidence in its business outlook and intrinsic value, which has positively impacted its stock price [1] Group 1: Stock Performance - The stock price of Corning Jereh Pharmaceutical-B rose over 7% in the afternoon trading session, with a current increase of 5.06%, reaching HKD 10.18 [1] - The trading volume amounted to HKD 18.5499 million [1] Group 2: Share Buyback Announcement - The board of directors resolved on November 7 to repurchase ordinary shares from the open market, with a maximum buyback amount of HKD 30 million [1] - The board believes that the current trading price does not accurately reflect the company's intrinsic value [1] - This buyback is expected to benefit the company and create value for its shareholders [1] - In October, the company had already announced a plan to repurchase up to HKD 20 million in shares [1]
港股异动 | 康宁杰瑞制药-B(09966)午后涨超7% 公司再次宣布回购 最高不超过3000万港元